CTRA vs EDIT · P/E 15, rev $5.46B vs rev $32.3M
Coterra Energy Inc (CTRA) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CTRA and EDIT stock pages for the full models.
Not investment advice.